Detalles de la búsqueda
1.
A Phase Ib Dose-Escalation Study of LCL161 Plus Oral Topotecan for Patients With Relapsed/Refractory Small Cell Lung Cancer and Select Gynecologic Malignancies.
Oncologist
; 28(7): 640-e559, 2023 07 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37129455
2.
Discordance in Tumor Mutation Burden from Blood and Tissue Affects Association with Response to Immune Checkpoint Inhibition in Real-World Settings.
Oncologist
; 27(3): 175-182, 2022 03 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35274716
3.
A Randomized, Double-Blinded, Phase II Trial of Carboplatin and Pemetrexed with or without Apatorsen (OGX-427) in Patients with Previously Untreated Stage IV Non-Squamous-Non-Small-Cell Lung Cancer: The SPRUCE Trial.
Oncologist
; 24(12): e1409-e1416, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31420467
4.
Phase 1, open-label, dose escalation, safety, and pharmacokinetics study of ME-344 as a single agent in patients with refractory solid tumors.
Cancer
; 121(7): 1056-63, 2015 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25411085
5.
A phase Ib study of linsitinib (OSI-906), a dual inhibitor of IGF-1R and IR tyrosine kinase, in combination with everolimus as treatment for patients with refractory metastatic colorectal cancer.
Invest New Drugs
; 33(1): 187-93, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25335932
6.
A phase 1 study of the sachet formulation of the oral dual PI3K/mTOR inhibitor BEZ235 given twice daily (BID) in patients with advanced solid tumors.
Invest New Drugs
; 33(2): 463-71, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25707361
7.
A first-in-human phase I dose-escalation, pharmacokinetic, and pharmacodynamic evaluation of intravenous LY2090314, a glycogen synthase kinase 3 inhibitor, administered in combination with pemetrexed and carboplatin.
Invest New Drugs
; 33(6): 1187-96, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26403509
8.
A phase I study of VS-6063, a second-generation focal adhesion kinase inhibitor, in patients with advanced solid tumors.
Invest New Drugs
; 33(5): 1100-7, 2015 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-26334219
9.
A Phase I Study of the Hsp90 Inhibitor AUY922 plus Capecitabine for the Treatment of Patients with Advanced Solid Tumors.
Cancer Invest
; 33(10): 477-82, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26460795
10.
A first-in-human dose-escalation study of ME-143, a second generation NADH oxidase inhibitor, in patients with advanced solid tumors.
Invest New Drugs
; 32(1): 87-93, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-23525756
11.
Phase Ib trial of the oral angiogenesis inhibitor pazopanib administered concurrently with erlotinib.
Invest New Drugs
; 31(4): 891-9, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23135778
12.
Population pharmacokinetics of PEGylated liposomal CPT-11 (IHL-305) in patients with advanced solid tumors.
Eur J Clin Pharmacol
; 69(12): 2073-81, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-23989300
13.
Phase 1 results from a study of romidepsin in combination with gemcitabine in patients with advanced solid tumors.
Cancer Invest
; 30(6): 481-6, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22536933
14.
Adavosertib with Chemotherapy in Patients with Primary Platinum-Resistant Ovarian, Fallopian Tube, or Peritoneal Cancer: An Open-Label, Four-Arm, Phase II Study.
Clin Cancer Res
; 28(1): 36-44, 2022 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34645648
15.
A phase I study of ispinesib, a kinesin spindle protein inhibitor, administered weekly for three consecutive weeks of a 28-day cycle in patients with solid tumors.
Invest New Drugs
; 29(3): 467-72, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-20069338
16.
A phase I trial of vatalanib (PTK/ZK) in combination with bevacizumab in patients with refractory and/or advanced malignancies.
Clin Adv Hematol Oncol
; 9(11): 845-52, 2011 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-22252616
17.
A phase I study of panobinostat in combination with gemcitabine in the treatment of solid tumors.
Clin Adv Hematol Oncol
; 9(3): 225-30, 2011 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-21475129
18.
Tumor-Specific and Tumor-Agnostic Molecular Signatures Associated With Response to Immune Checkpoint Inhibitors.
JCO Precis Oncol
; 5: 1625-1638, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34994650
19.
Next-Generation Sequencing of Patients With Breast Cancer in Community Oncology Clinics.
JCO Precis Oncol
; 5: 1297-1311, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34994634
20.
A phase I study of weekly topotecan in combination with pemetrexed in patients with advanced malignancies.
Oncologist
; 15(9): 954-60, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-20798192